WHO urges action as drug-resistant malaria spreads

September 27, 2012

The World Health Organization said Thursday that governments in the Mekong region must act "urgently" to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar.

There is growing evidence that the is becoming resistant to a frontline treatment, the anti-malarial drug artemisinin, in southern and central Vietnam and in southeastern Myanmar, the WHO said in a statement.

Drug- was found on the Thailand-Cambodia border eight years ago, and has since also been discovered along the Thailand-Myanmar border, according to scientists.

WHO regional director, Shin Young-soo, said countries must "urgently address this issue before we put at risk not only the fragile gains we have made in but also our goal of a malaria-free Western Pacific Region."

Countries in the Mekong region must "intensify and expand" operations to contain and eliminate artemisinin-resistant malaria, Shin said at a WHO regional meeting in Hanoi.

Drug-resistant malaria in Vietnam is mainly concentrated in three central and southern provinces, say health officials, adding that there are a number of key factors which make tackling the problem difficult in the communist country.

The population in the affected provinces are very poor, highly mobile, and have not widely embraced DEET-treated which could reduce malaria infections, according to media reports of a government conference in July.

People in the affected provinces often received outpatient treatment and frequently fail to complete a full course of anti-malarial treatment.

Resistance to does not prevent patients being cured, thanks to other partner drugs, but treatment typically takes a few days instead of 24 hours.

Malaria is a life-threatening disease caused by parasites that are transmitted through the bites of infected mosquitoes.

It killed an estimated 655,000 people in 2010, mostly African children, although mortality rates have fallen sharply over the past decades, according to the WHO.

Explore further: WHO hopeful drug-resistant malaria can be contained

Related Stories

WHO hopeful drug-resistant malaria can be contained

April 24, 2012
The World Health Organisation said Tuesday it was optimistic drug-resistant malaria that has emerged along Thailand's borders with Cambodia and Myanmar could be contained within the region.

Study finds early signs of malaria drug resistance in Africa

April 27, 2012
Africa's deadliest malaria parasite has shown resistance in lab tests to one of the most powerful drugs on the market -- a warning of possible resistance to follow in patients, scientists said Friday.

New artemisinin-based treatment against malaria promising

November 8, 2011
For some time now, artemisinin, derived from a Chinese herb, has been the most powerful treatment available against malaria. To avoid the malaria parasite becoming resistant, the World Health Organisation (WHO) strongly recommends ...

Screening effort turns up multiple potential anti-malaria compounds

August 4, 2011
Numerous potential anti-malarial candidate drugs have been uncovered by investigators from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI), both parts ...

Artemisinin-resistant untreatable malaria increasing rapidly along the Thailand-Myanmar border: study

April 5, 2012
Evidence that the most deadly species of malaria parasite, Plasmodium falciparum, is becoming resistant to the front line treatment for malaria on the border of Thailand and Myanmar (Burma) is reported in The Lancet today. ...

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.